Page last updated: 2024-08-23

idarubicin and xylose

idarubicin has been researched along with xylose in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Bow, EJ; Gallant, G; Rubinger, M; Schacter, BA; Shore, TB; Williams, GJ; Woloschuk, D	1
Blijlevens, NM; de Pauw, BE; Donnelly, JP; M'Rabet, L; van't Land, B	1

Trials

1 trial(s) available for idarubicin and xylose

Article	Year
Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Cancer, 1998, Oct-01, Volume: 83, Issue:7 Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Idarubicin; Intestinal Mucosa; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Xylose	1998

Article

Year

Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.

Cancer, 1998, Oct-01, Volume: 83, Issue:7

Topics: Acute Disease; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Drug Tolerance; Etoposide; Female; Humans; Idarubicin; Intestinal Mucosa; Leukemia, Myeloid; Male; Middle Aged; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Xylose

1998

Other Studies

2 other study(ies) available for idarubicin and xylose

Article	Year
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Measuring mucosal damage induced by cytotoxic therapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:4 Topics: 3-O-Methylglucose; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Leukemia, Myeloid; Male; Middle Aged; Mouth Mucosa; Myelodysplastic Syndromes; Permeability; Rhamnose; Stomatitis; Transplantation Conditioning; Whole-Body Irradiation; Xylose	2004

Article

Year

Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.

Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

Topics:

2008

Measuring mucosal damage induced by cytotoxic therapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2004, Volume: 12, Issue:4

Topics: 3-O-Methylglucose; Acute Disease; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Intestinal Mucosa; Lactulose; Leukemia, Myeloid; Male; Middle Aged; Mouth Mucosa; Myelodysplastic Syndromes; Permeability; Rhamnose; Stomatitis; Transplantation Conditioning; Whole-Body Irradiation; Xylose

2004